NEW YORK / RankWire.AI / – On Wednesday, U.S. equities experienced modest increases as long-term Treasury yields declined sharply. The S&P 500 added 16.22 points, or 0.21%, closing at 7,707.98 and ending a three-day losing streak. The Dow Jones Industrial Average rose by 119.65 points, or 0.22%, finishing at 53,463.05. The Nasdaq Composite increased by 41.38 points, or 0.16%, ending at 26,331.09. The decline in government bond yields helped major indexes recover after several sessions of downward pressure caused by rising borrowing costs.
Bond prices moved upward following the U.S. Treasury Department’s announcement of increased liquidity support through larger debt buybacks for longer-term securities. Beginning September 9, the maximum purchase amount will be raised from $2 billion to at least $4 billion per operation. This adjustment applies to nominal coupon securities within the 10-to-20-year and 20-to-30-year maturity ranges. The increased purchase limits will remain in effect until November 4. The department cited robust high-quality offer volumes as the basis for expanding liquidity operations in these sectors.
Treasury yields responded to the news by moving lower, partially reversing the recent rise in long-term borrowing costs. The 10-year Treasury yield decreased to roughly 4.65%, while the 30-year yield fell to about 5.20%. On Tuesday, the 30-year yield had reached 5.337%, its highest level since 2007. Because bond yields and prices move inversely, the increased demand for government debt resulted in lower yields. This retreat alleviated some of the pressure that had accompanied the recent selloff in longer-term bonds.
Healthcare Sector Spurs Market Momentum
Wednesday’s session saw healthcare stocks bolster overall gains, as several pharmaceutical firms posted strong results. Moderna shares surged by 177%, while Merck increased by 12.6% after announcing positive outcomes from a Phase 3 melanoma trial. The INTerpath-001 study evaluated personalized mRNA therapy intismeran autogene combined with Keytruda after surgical removal of high-risk melanoma. The trial met its primary endpoint for recurrence-free survival and also achieved a key secondary endpoint measuring survival without distant cancer spread.
This healthcare rally helped offset mixed trading patterns in other sectors, particularly within technology. Consumer-related stocks also contributed as several major companies reported quarterly earnings during the session. Estée Lauder rose over 16% following its earnings report, adding to gains in the consumer sector. Target and Lowe’s also advanced after releasing their latest financial results. Smaller-cap stocks outperformed their large-cap counterparts, with the Russell 2000 climbing approximately 0.5% as the broader market rebounded.
Major Indices End Losing Streak
Wednesday’s gains marked the end of a three-day decline for the S&P 500, Dow, and Nasdaq. The rebound followed earlier in the week when higher long-term yields had exerted downward pressure on equities. Despite Wednesday’s positive movement, the main indexes still finished lower for the week. The S&P 500 was approximately 1% below last Friday’s level. The Dow had declined by about 0.5% for the week, and the Nasdaq was roughly 1.5% lower.
Nevertheless, the broader year-to-date performance remained optimistic despite the weekly downturn and recent bond market stress. As of Wednesday’s close, the S&P 500 was up about 12.6% since the beginning of the year. The Dow had gained approximately 11.2%, while the Nasdaq led with a 13.3% increase, reflecting its stronger early-year rally. Wednesday’s session thus provided a modest recovery for Wall Street, supported by declining Treasury yields and healthcare sector gains that lifted all three major U.S. stock indexes.